one in five. When many applications are of a high quality, low success rates increase to an undesirable level the influence of chance in decision making. This is bad for the overall research enterprise and is demotivating for the investigators making applications.
The increased pressure on NIH resources focuses attention on the mechanisms by which research support allocations are made. The application process is very time consuming and is generally considered to be risk averse. The documentation required for an average research project grant application of $250,000 per year is 25 pages in length, and sometimes further rewrites are requested by the evaluating study section committee before a final decision is made. The level of detail needed for these grants is very considerable, and this, together with the low success rate, puts significant demands on the committee members who decide which grants should be funded. The present situation also encourages conservatism both in applicants and assessors. Innovative applications tend not to be supported because they are considered too risky, and the general strategy used by most applicants is to propose projects that are already largely completed because these will be less vulnerable to criticism.
This stagnation in research funding is placing great pressure on the US biomedical research enterprise. There is a pressing need to re-examine the overall Federal budget so that at the very least the present budget level is preserved. A compelling case for yet further expansion has been made in a recent report from the US National Academies of Sciences and Engineering and the Institute of Medicine; the report recommends an increase in science research funding of 10% per year for the next 7 years. Equally important as increasing the overall budget is a more thoughtful analysis of the impact of budgetary changes. Rapid expansion followed by stagnation is particularly damaging given the age structure of research groups. Biomedical research groups are composed largely of young scientists in training, most often students and postdoctoral researchers, nearly all of whom will be under 35 years of age. This age structure is inherently unstable because although many young scientists are being trained, there are relatively few principal investigator group leader positions available for them later in their careers. When budgets expand, more students and postdoctoral scientists are required to drive the engine of research, and universities and institutes construct larger research facilities to take advantage of the increased funds and indirect costs that become available. Several years after such a budget expansion, there will be a further increase in the numbers of trainees searching for independent principal investigator positions. If at the same time funding stagnates, then an already difficult problem becomes almost impossible to manage. This is what is happening with the present budget trajectory for NIH. Much more attention needs to be paid to the effects of such stopgo funding. Present policies are set to damage a whole generation of young research workers, and the negative impact on recruitment of the next generation of research scientists will be seen for years to come.
More radical solutions to this problem also need to be considered.
For decades, the United States has been the unchallenged world leader in biomedical research. Spending by the US on scientific research is the highest in the world, winners of major biomedical research prizes such as the Nobel and Lasker have largely been drawn from scientists working in the US, research output as judged by publications, scientific advances, and innovative biotechnological and clinical applications is high, and the US has long been a magnet for the best research talent from around the world. This leading position has meant that US biomedical scientists have always expressed great confidence in their country's research enterprise. So as a newcomer to American science, it is a surprise for me to see the slippage in confidence that has occurred during the last couple of years. Worries and anxieties abound. Barely a day goes by without a scientist expressing concern over issues such as levels of funding, recruitment of researchers, restrictions on research projects, and potential political interference in scientific judgments. Is biomedical research in the US under siege and, if so, what can be done about it?
Nothing saps morale more than anxieties over research funding. After the dramatic rise in support for the National Institutes of Health (NIH), which has led to a doubling in research funds from 1998 to 2003, increases in the last 3 years have struggled to keep pace with inflation. The outlook is worsening, with many expecting the overall budget to increase less than inflation, leading to a decline in the real size of individual research grants. The success rate of awards compared with applications has slipped from close to one in three in the late 1990s to nearly
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Research groups could be smaller, potentially allowing principal investigators to continue as active experimentalists for more of their career rather than being diverted at an early stage into constant grant writing. Smaller research groups could come together into larger groupings for particular projects, with these groupings forming and dissolving as the science demands. Such a structure could also encourage more interdisciplinary research. These cultural changes would result in more independent principal investigator positions, improving the overall career structure for research workers. Similarly, the mechanisms by which research support allocations are made need to be overhauled. The grant funding processes followed by government agencies in other countries and by some non-Federal private funding agencies are less lengthy and time consuming than that used by the NIH. Shorter, less-detailed applications can be sufficient for effective decision making if well structured and could encourage less conservative applications. One of the very best guides to future achievement is past accomplishment, and so for many established researchers, greater emphasis could be given to assessing what they have accomplished in the recent past. Such an approach simplifies assessment and shifts the emphasis from future research project appraisals, which are subjective and difficult to judge, toward the capability of the individual researcher where criteria can be more objective. Such an ad hominem approach has been used very effectively by one of the most successful of the US biomedical research organizations, the Howard Hughes Medical Institute. Of course, not all researchers are at a career stage when they can be judged by past achievement, and assessment in their cases will require greater attention to their proposed future projects. Younger researchers starting their careers and those applying for research support after a less productive period would fall in this category. Even so, the overall work load for applicants and assessors as well as the quality of decision making would be considerably improved by more emphasis on past achievement. The use of ad hominem approaches could also be expanded for postdoctoral researchers of high quality. If they, rather than the principal investigator, were awarded the funds to support their salary and research and if they had greater freedom to later change the research group in which they work, then postdoctoral mentoring might also be improved. However, politicians may resist putting more emphasis on ad hominem and past performance criteria for research grant assessment. Politicians have seldom been directly exposed to the research process and do not always understand how it works. They are likely to feel that specific research projects should be identified and supported and will be uncomfortable with the idea of putting more emphasis on supporting a talented individual rather than a project because it will seem that they are not taking their public responsibilities seriously. Politicians would benefit from better guidance on how to assess scientific research more effectively.
A second major issue sapping the confidence of US biomedical researchers is the increasing opinion that the present political leadership and certain influential parts of US society appear to have little understanding of, or respect for, science. For many decades, the US has had a reputation for respecting the pursuit of knowledge and for recognizing that science forms the basis for commercial innovation, technological advances, better health, and improvements in the quality of life and the environment. Many would argue that the pre-eminent commercial strength of the US is directly related to the strength of its scientific base. However, scientists are now beginning to wonder whether the present political climate is still sympathetic to this approach.
Two scientific issues illustrate these concerns: the debate over Darwinism and Creationism and research on human embryonic stem cells. The attack on Darwinism by supporters of Intelligent Design is a straightforward attack on science itself. Intelligent Design is not science because it proposes a supernatural designer as an explanation for evolutionary change. It is quite extraordinary that the Scopes trial of the 1920s is once again being revisited in parts of the US where attempts are being made to replace scientific teaching in schools with explanations based on religious beliefs. President Bush commented on this issue when a group of Texas newspaper reporters asked whether Intelligent Design should be taught alongside evolution as competing theories. His response was, "Both sides ought to be properly taught…so people can understand what the debate is about." This unfortunate reply allowed Creationists to claim that the US political leadership supported their antiscientific views, and tellingly these claims brought no response from the President to clarify the matter. Even senior leaders of US biomedical science seem to be rather nervous about taking a stand over the Creationism issue. When the NIH Director, Dr. Elias Zerhouni, was asked by Science magazine whether he was personally concerned about the Intelligent Design movement taking off in schools, he said, "I am very concerned about it. And I don't think it's a good direction." But in the same interview when asked why NIH had not been very visible in the debate over Intelligent Design, his response was "Why should it? Why do you think NIH should be visible in that debate?" One answer is that if human pathogens are being intelligently designed in response to the evolutionary pressures brought about by prolonged exposure to antibiotics, changes will be required in the current NIH strategies used to combat infectious diseases. Dr. Zerhouni has a difficult job spanning the political and scientific worlds, but it is crucial that great US scientific institutions like the NIH are unequivocal in their defense of science, especially over an issue that is as fundamental to biomedicine as Darwinism. This is a very important matter because the failure of the leadership to robustly support science will eventually be damaging for the whole scientific enterprise in the US.
The debate over human embryonic stem cells is more complex but also has consequences beyond the immediate issue of defining the types of experiments that are permissible. It is complex because it embraces difficult ethical questions such as when does life begin and the appropriateness of taking what some see as an overly utilitarian approach to the early human embryo. What has been lacking is a reasoned dialog among society, politicians, and scientists to debate these issues, and this failure has led to poor legislation. Present NIH guidelines allow federal support only for the socalled Presidential human embryonic stem cell lines made prior to August 2001. Any research using stem cell lines made after this arbitrary date cannot be funded by federal money, and indeed any investigator or institution making or using such cell lines with federal support could be severely punished.
This limitation made little sense to many people when initially drafted, given that the early human embryos used for stem cell derivation were obtained from fertility clinics and were in excess of clinical requirements. It makes less sense now given that only a small handful of the Presidential stem cell lines remain viable and useful for research and, in any case, none of these lines can be used for clinical applications. What further underscores the inconsistency of this approach is the fact that human embryonic stem cell lines can still be made and experimented with if such work is privately funded, indicating that the political leadership does not consider that US society as a whole thinks that it is morally repugnant because, if it did so, such work should have been banned regardless of the funding source. A further significant consequence of the present arrangements is that scientists and their host institutions pursuing human embryonic stem cell work have been placed in a deeply uncomfortable, almost intolerable situation. The quarantine measures demanded by NIH to keep private and federal funding totally separate raise the extraordinary possibility that, should one eppendorf tube bought with NIH funds be used accidentally in human embryonic stem cell research, all the NIH funds awarded to that institution might be at risk. Even more disturbing is that, in this atmosphere of fear, strangely reminiscent of Galileo being shown the instruments of torture because of his heliocentric views, the scientific community may begin to lose its confidence and start to turn on itself. Scientists receiving federal funding in areas related to stem cell work may start to criticize their colleagues who they think are "rocking the boat." Confidential peer review of publications and grants will be at risk of becoming increasingly more conservative as individual scientists become concerned that federal support for their own work may be put in jeopardy if too much attention is drawn to the human embryonic stem cell field by work that may be seen to be controversial. Such self-censorship becomes a threat to academic freedom. Scientists need courage to prevent such developments and to ensure that their colleagues carrying out human embryonic stem cell research are adequately defended by the scientific community. The whole issue of stem cells reflects the pressing need for more debate and better dialog with the public about scientific issues.
A further concern for biomedical researchers is recruitment. An unfortunate consequence of the terrible September 11, 2001 attack on New York City has been increased visa and immigration restrictions combined with a mounting sense of "Fortress America" increasingly trying to insulate itself from the rest of the world. The numbers of overseas students coming to the US has significantly dropped since 2001, and stories of increased bureaucracy and long delays in visa processing are common. This shift is alien to the well-established US tradition of encouraging the immigration of talented individuals and visiting scholars from overseas. The stimulating and invigorating "melting-pot" conditions that prosper when different cultures and traditions meet and interact are extremely important for scientific research. High-quality innovative science and, for that matter, thriving industry and trade prosper in interactive and outgoing societies as seen during the Golden Age of seventeenth century Holland, Victorian times in nineteenth century England, and the twentieth century in the US. The problem is made more acute because the US fails to generate enough homegrown scientists to drive the scientific endeavor. Despite heroic efforts from the US National Academy of Sciences to improve science teaching in schools, insufficient numbers of students are taking up science, and this shortfall can be made up only by students and scholars coming from overseas.
Crucial to dealing with these problems is the need to persuade America's political leaders that they must take science more seriously. Politicians will only do that if they judge that society more generally believes that science really matters. Science is important to society because it is essential both for achieving a better quality of life and for sustaining an effective democracy in an increasingly technological age. Two of the factors that can help to raise the profile of science in society are better science education in schools and improved dialog with the public over scientific issues.
Teaching science well in schools is difficult, and for many years it has been recognized that science education in US schools needs to be improved. Good science teaching will enable adult citizens to participate more effectively in political decisions involving science, and more people will be drawn to working in the scientific endeavor. The characteristic features of science need to be communicated to students in schools; these include respect for objective evidence and observation, reliance on rational argument, encouragement of skepticism, the need for consistency, and providing the most reliable understanding of the natural world. The fact that scientific explanations at the boundaries of knowledge are often tentative also needs to be emphasized at school so that later in life, citizens will better appreciate the complex issues that arise when science meets politics. Most importantly, schools must resist those who deliberately confuse religion with science in their attempts to impose their own religious beliefs on the classroom in the guise of science. Today, Creationists promoting Intelligent Design as science are leading that antiscience lobby, and this movement must be vigorously opposed.
Better dialog with the public about science and issues raised by science is fundamental for a good relationship between science and society. In recent years, the communication of science to the public has much improved with many excellent popular books and mass media programs about science. But this communication has usually been only one way, from the scientist to the public, which does not reflect a true dialog. Scientists need to listen to the public as well, because that is the only way that we can really find out what scientific issues matter to the average person and what they think about those issues. Scientists should become more engaged at this grass roots level, not just with the intellectual elites, but with all parts of society in all parts of the country. This dialog should be open, responsive, and courteous, rejecting the polarized debates promoted by the media; the discussion of scientific issues is not well suited to a combative and confrontational approach. To help advance such dialog, scientists could volunteer to promote discussions in schools and should prevail upon national science societies to organize dialog meetings with the general public. If the public becomes more concerned with science, then the political leadership will take science more seriously. Scientists need to earn the trust and confidence of the public if we are to retain our "license to operate." But to do that we have to be accurate about what science can do. It is no good exaggerating what science can deliver, as happened when the Director of the National Cancer Institute, Dr. Andrew von Eschenbach, announced the Institute's challenge goal in 2003 as "To eliminate the suffering and death due to cancer by 2015." This cannot be justified even as a statement of aspiration because when we fail to deliver, as we surely will with such a claim, we will lose the confidence and trust of both the politicians and the public.
Biomedical research is still very strong in the US but is under siege. Unless this trend is corrected, science will be damaged by both stagnation in research funding and the failure of the political leadership to take science seriously. These are unfortunate developments, given that the founding principles of the Republic forged at the height of the Enlightenment are imbued with a respect for openness, rationalism, and decisions based on objective evidence and observation. These same values are core to the scientific endeavor, and we scientists have a responsibility to engage with politicians and society in the US to ensure both the continued pursuit of scientific knowledge and the use of that knowledge for the benefit of humanity.
